Revelation Biosciences (REVB)
NASDAQ:REVB
US Market
Holding REVB?
Track your performance easily

Revelation Biosciences (REVB) Financial Statements

102 Followers

Revelation Biosciences Financial Overview

Revelation Biosciences's market cap is currently ―. The company's EPS TTM is $-28.439; its P/E ratio is -0.03; Revelation Biosciences is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-2.84. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -8.39M$ -2.68M$ -2.63M$ -1.45M$ 6.16M
EBITDA$ -8.38M$ -2.68M$ -2.62M$ -1.44M$ 6.17M
Net Income Common Stockholders$ -8.39M$ -2.70M$ -2.63M$ -1.45M$ 6.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.07M$ 14.55M$ 13.99M$ 15.71M$ 17.70M
Total Assets$ 12.27M$ 14.70M$ 14.22M$ 16.04M$ 18.12M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -12.07M$ -14.55M$ -13.99M$ -15.71M$ -17.70M
Total Liabilities$ 11.13M$ 5.23M$ 5.40M$ 4.62M$ 8.10M
Stockholders Equity$ 1.14M$ 9.47M$ 8.82M$ 11.41M$ 10.02M
Cash Flow-
Free Cash Flow$ -2.48M$ -2.86M$ -1.72M$ -1.99M$ -1.58M
Operating Cash Flow$ -2.48M$ -2.84M$ -1.72M$ -1.99M$ -1.58M
Investing Cash Flow-$ -19.17K---
Financing Cash Flow-$ 5.42M-$ 15.00$ 14.02M
Currency in USD

Revelation Biosciences Earnings and Revenue History

Revelation Biosciences Debt to Assets

Revelation Biosciences Cash Flow

Revelation Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis